Trial Condition(s):

Contraception, Menorrhagia, Endometrial Hyperplasia, Estrogen replacement therapy

Mirena observational program

Bayer Identifier:

14474

ClinicalTrials.gov Identifier:

NCT00883662

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy

Inclusion Criteria
- Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications
Exclusion Criteria
- All patients with contraindications to Mirena insertion, according to approved prescribing information.

Trial Summary

Enrollment Goal
2725
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Mirena (Levonorgestrel IUS, BAY86-5028)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Kazakhstan

Status
Completed
 

Trial Design